+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nutrigenomics Market By Product Type, By Applications, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • PDF Icon

    Report

  • 280 Pages
  • January 2024
  • Region: Global
  • Allied Market Research
  • ID: 5941241
Nutrigenetics studies the presence of a particular gene variant or polymorphism that in most cases merely connotes a predisposition to a particular disease process that may be prevented through a complex interplay of environmental and behavioral factors such as a personalized nutrition. Nutrigenomics refers to the study of the effects of specific nutrients or nutraceuticals on the expression of an individual’s genetic makeup.

Rising prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases is driving the growth of the nutrigenomics testing market. Over the past decade, rapid advancements in omic technologies such as proteomics, genomics, and metabolomics are combining with advanced bioinformatics to be broadly used for identifying diseases based on protein pathways. Currently, the findings of nutrigenomics have been used to some extent to treat diseases with a diet component like diabetes, cancer, and obesity, significantly boosting the nutrigenomics testing market size.

Accuracy and reliability of the nutrigenomic test findings is one of the major concerns for most of the consumers. Direct-to-consumer tests including nutrigenomic tests have varying levels of evidence that support their claims. Some direct-to-consumer tests have more scientific and clinical data to support the information provided in the test, while other tests do not have as much supporting data. Furthermore, disagreements in the clinical community about the role that different genetic variants are contributing to the disease is another reason affecting the accuracy and reliability of the test. Moreover, not all variants contribute to an individual’s risk of getting a disease or condition, so it is important that customers understand that a negative result does not mean that the individual is free from the risk of developing a particular disease or condition. As different companies test for the different set of variants, therefore the same nutrigenomics tests might provide different results for the same disease. Thus, customers need to use their own judgment while ordering and interpreting the results from nutrigenomic tests. Therefore, nutrigenomics test results are not considered as accurate and reliable, further hampering the overall demand.

Sport nutrigenomics is another significant opportunity for nutrigenomics testing market. Thus, athletes are looking for tailor-made diets for improving their health status. Personalized nutrition in athletic populations aims in optimizing health, body composition, and exercise performance by targeting dietary recommendations to an individual's genetic profile. Sport dietitians and nutritionists have long been skilled at placing additional analysis on the one-size-fits-all general population dietary guidelines to accommodate various sporting populations. However, generic ‘one-size-fits-all’ recommendations still remain. Genetic differences are known to impact absorption, metabolism, uptake, utilization, and excretion of nutrients and food bio actives, which ultimately affects a number of metabolic pathways. Nutrigenomics and nutrigenetics are experimental approaches that use genomic information and genetic testing technologies to examine the role of individual genetic differences in modifying an athlete's response to nutrients and other food components. Although there have been few randomized, controlled trials examining the effects of genetic variation on performance in response to an ergogenic aid, there is a growing foundation of research linking gene-diet interactions on biomarkers of nutritional status, which impact exercise and sport performance. This foundation forms the basis from which the field of sport nutrigenomics continues to develop.

The COVID-19 pandemic had significant impacts on the nutrigenomics testing market growth. The pandemic introduced many new users to telehealth and further reinforced its benefits to potential competitors. In turn, the COVID-19 pandemic has also driven additional industry consolidation or collaboration within the nutrigenomics market. Furthermore, the COVID-19 pandemic, and its resulting changes in consumer behavior and expectations, has also caused various traditional healthcare providers to evaluate and pursue telehealth options that can be paired with their in-person capabilities. Also, telehealth awareness, acceptance, and usage have been positively impacted by the COVID-19 pandemic, leading to increased consumer acceptance of virtual care. Thus, the pandemic led to an increase in the utilization of telehealth services, which is anticipated to boost the nutrigenomics market in the post-pandemic period.

Some of the companies operating in the cybersecurity in banking market are Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nutrigenomics market analysis from 2022 to 2032 to identify the prevailing nutrigenomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nutrigenomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nutrigenomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Consumer Buying Behavior Analysis
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • Pain Point Analysis
  • Regulatory Guidelines
  • Strategic Recommedations
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents and Kits
  • Services

By Applications

  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
  • Obesity

By End User

  • Online Platforms
  • Hospitals and Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Cura Integrative Medicine
  • Holistic Health
  • Metagenics, Inc.
  • GX Sciences Inc.
  • The Gene Box
  • Nutrigenomix Inc.
  • Xcode Life
  • DNA Life
  • Interleukin Genetics
  • Genova Diagnostics

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Market Share Analysis
3.6. Brand Share Analysis
3.7. Value Chain Analysis
3.8. Regulatory Guidelines
3.9. Key Regulation Analysis
CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Kits
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS
5.1. Overview
5.1.1. Market size and forecast
5.2. Obesity
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Diabetes
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Cardiovascular Diseases
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Cancer Research
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Online Platforms
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hospitals and Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Applications
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Applications
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Applications
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Applications
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Applications
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Applications
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Applications
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Applications
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Spain
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Applications
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Italy
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Applications
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Applications
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Applications
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Applications
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Applications
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Applications
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. South Korea
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Applications
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. Australia
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Applications
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Applications
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Applications
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Applications
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. UAE
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Applications
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Applications
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. South Africa
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Applications
7.5.5.4.3. Market size and forecast, by End User
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by Product Type
7.5.5.5.2. Market size and forecast, by Applications
7.5.5.5.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Cura Integrative Medicine
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.2. Holistic Health
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.3. Metagenics, Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.4. GX Sciences Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.5. The Gene Box
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.6. Nutrigenomix Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.7. Xcode Life
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.8. DNA Life
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.9. Interleukin Genetics
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.10. Genova Diagnostics
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
List of Tables
Table 01. Global Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 02. Nutrigenomics Market for Reagents and Kits, by Region, 2022-2032 ($Million)
Table 03. Nutrigenomics Market for Services, by Region, 2022-2032 ($Million)
Table 04. Global Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 05. Nutrigenomics Market for Obesity, by Region, 2022-2032 ($Million)
Table 06. Nutrigenomics Market for Diabetes, by Region, 2022-2032 ($Million)
Table 07. Nutrigenomics Market for Cardiovascular Diseases, by Region, 2022-2032 ($Million)
Table 08. Nutrigenomics Market for Cancer Research, by Region, 2022-2032 ($Million)
Table 09. Global Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 10. Nutrigenomics Market for Online Platforms, by Region, 2022-2032 ($Million)
Table 11. Nutrigenomics Market for Hospitals and Clinics, by Region, 2022-2032 ($Million)
Table 12. Nutrigenomics Market for Others, by Region, 2022-2032 ($Million)
Table 13. Nutrigenomics Market, by Region, 2022-2032 ($Million)
Table 14. North America Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 15. North America Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 16. North America Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 17. North America Nutrigenomics Market, by Country, 2022-2032 ($Million)
Table 18. U.S. Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 19. U.S. Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 20. U.S. Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 21. Canada Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 22. Canada Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 23. Canada Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 24. Mexico Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 25. Mexico Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 26. Mexico Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 27. Europe Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 28. Europe Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 29. Europe Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 30. Europe Nutrigenomics Market, by Country, 2022-2032 ($Million)
Table 31. Germany Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 32. Germany Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 33. Germany Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 34. UK Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 35. UK Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 36. UK Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 37. France Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 38. France Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 39. France Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 40. Spain Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 41. Spain Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 42. Spain Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 43. Italy Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 44. Italy Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 45. Italy Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 46. Rest of Europe Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 47. Rest of Europe Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 48. Rest of Europe Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 49. Asia-Pacific Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 50. Asia-Pacific Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 51. Asia-Pacific Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 52. Asia-Pacific Nutrigenomics Market, by Country, 2022-2032 ($Million)
Table 53. China Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 54. China Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 55. China Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 56. Japan Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 57. Japan Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 58. Japan Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 59. India Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 60. India Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 61. India Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 62. South Korea Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 63. South Korea Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 64. South Korea Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 65. Australia Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 66. Australia Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 67. Australia Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 68. Rest of Asia-Pacific Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 69. Rest of Asia-Pacific Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 70. Rest of Asia-Pacific Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 71. LAMEA Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 72. LAMEA Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 73. LAMEA Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 74. LAMEA Nutrigenomics Market, by Country, 2022-2032 ($Million)
Table 75. Brazil Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 76. Brazil Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 77. Brazil Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 78. UAE Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 79. UAE Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 80. UAE Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 81. Saudi Arabia Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 82. Saudi Arabia Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 83. Saudi Arabia Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 84. South Africa Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 85. South Africa Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 86. South Africa Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 87. Rest of LAMEA Nutrigenomics Market, by Product Type, 2022-2032 ($Million)
Table 88. Rest of LAMEA Nutrigenomics Market, by Applications, 2022-2032 ($Million)
Table 89. Rest of LAMEA Nutrigenomics Market, by End-user, 2022-2032 ($Million)
Table 90. Cura Integrative Medicine: Key Executives
Table 91. Cura Integrative Medicine: Company Snapshot
Table 92. Holistic Health: Key Executives
Table 93. Holistic Health: Company Snapshot
Table 94. Metagenics, Inc.: Key Executives
Table 95. Metagenics, Inc.: Company Snapshot
Table 96. Gx Sciences Inc.: Key Executives
Table 97. Gx Sciences Inc.: Company Snapshot
Table 98. the Gene Box: Key Executives
Table 99. the Gene Box: Company Snapshot
Table 100. Nutrigenomix Inc.: Key Executives
Table 101. Nutrigenomix Inc.: Company Snapshot
Table 102. Xcode Life: Key Executives
Table 103. Xcode Life: Company Snapshot
Table 104. DNA Life: Key Executives
Table 105. DNA Life: Company Snapshot
Table 106. Interleukin Genetics: Key Executives
Table 107. Interleukin Genetics: Company Snapshot
Table 108. Genova Diagnostics: Key Executives
Table 109. Genova Diagnostics: Company Snapshot
List of Figures
Figure 01. Nutrigenomics Market, 2022-2032
Figure 02. Segmentation of Nutrigenomics Market,2022-2032
Figure 03. Top Impacting Factors in Nutrigenomics Market
Figure 04. Top Investment Pockets in Nutrigenomics Market (2023-2032)
Figure 05. Bargaining Power of Suppliers
Figure 06. Bargaining Power of Buyers
Figure 07. Threat of Substitution
Figure 08. Threat of Substitution
Figure 09. Competitive Rivalry
Figure 10. Global Nutrigenomics Market:Drivers, Restraints and Opportunities
Figure 11. Regulatory Guidelines: Nutrigenomics Market
Figure 12. Impact of Key Regulation: Nutrigenomics Market
Figure 13. Nutrigenomics Market, by Product Type, 2022 and 2032(%)
Figure 14. Comparative Share Analysis of Nutrigenomics Market for Reagents and Kits, by Country 2022 and 2032(%)
Figure 15. Comparative Share Analysis of Nutrigenomics Market for Services, by Country 2022 and 2032(%)
Figure 16. Nutrigenomics Market, by Applications, 2022 and 2032(%)
Figure 17. Comparative Share Analysis of Nutrigenomics Market for Obesity, by Country 2022 and 2032(%)
Figure 18. Comparative Share Analysis of Nutrigenomics Market for Diabetes, by Country 2022 and 2032(%)
Figure 19. Comparative Share Analysis of Nutrigenomics Market for Cardiovascular Diseases, by Country 2022 and 2032(%)
Figure 20. Comparative Share Analysis of Nutrigenomics Market for Cancer Research, by Country 2022 and 2032(%)
Figure 21. Nutrigenomics Market, by End-user, 2022 and 2032(%)
Figure 22. Comparative Share Analysis of Nutrigenomics Market for Online Platforms, by Country 2022 and 2032(%)
Figure 23. Comparative Share Analysis of Nutrigenomics Market for Hospitals and Clinics, by Country 2022 and 2032(%)
Figure 24. Comparative Share Analysis of Nutrigenomics Market for Others, by Country 2022 and 2032(%)
Figure 25. Nutrigenomics Market by Region, 2022 and 2032(%)
Figure 26. U.S. Nutrigenomics Market, 2022-2032 ($Million)
Figure 27. Canada Nutrigenomics Market, 2022-2032 ($Million)
Figure 28. Mexico Nutrigenomics Market, 2022-2032 ($Million)
Figure 29. Germany Nutrigenomics Market, 2022-2032 ($Million)
Figure 30. UK Nutrigenomics Market, 2022-2032 ($Million)
Figure 31. France Nutrigenomics Market, 2022-2032 ($Million)
Figure 32. Spain Nutrigenomics Market, 2022-2032 ($Million)
Figure 33. Italy Nutrigenomics Market, 2022-2032 ($Million)
Figure 34. Rest of Europe Nutrigenomics Market, 2022-2032 ($Million)
Figure 35. China Nutrigenomics Market, 2022-2032 ($Million)
Figure 36. Japan Nutrigenomics Market, 2022-2032 ($Million)
Figure 37. India Nutrigenomics Market, 2022-2032 ($Million)
Figure 38. South Korea Nutrigenomics Market, 2022-2032 ($Million)
Figure 39. Australia Nutrigenomics Market, 2022-2032 ($Million)
Figure 40. Rest of Asia-Pacific Nutrigenomics Market, 2022-2032 ($Million)
Figure 41. Brazil Nutrigenomics Market, 2022-2032 ($Million)
Figure 42. UAE Nutrigenomics Market, 2022-2032 ($Million)
Figure 43. Saudi Arabia Nutrigenomics Market, 2022-2032 ($Million)
Figure 44. South Africa Nutrigenomics Market, 2022-2032 ($Million)
Figure 45. Rest of LAMEA Nutrigenomics Market, 2022-2032 ($Million)
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Nutrigenomics Market
Figure 49. Top Player Positioning, 2022

Companies Mentioned

  • Cura Integrative Medicine
  • Holistic Health
  • Metagenics, Inc.
  • GX Sciences Inc.
  • The Gene Box
  • Nutrigenomix Inc.
  • Xcode Life
  • DNA Life
  • Interleukin Genetics
  • Genova Diagnostics

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...